 BETHESDA, Md., March 25, 2021 GLOBE NEWSWIRE -- Gain Therapeutics, Inc. Gain today announced the closing of its initial public offering of 3,636,364 shares of its common stock and full exercise of the underwriters overallotment option to purchase 545,454 additional shares of common stock, at a public offering price of 11.00 per share. The gross proceeds to Gain from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Gain, were approximately 46 million. 